Gene Editing Market: Global Market Size, Growrh, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Gene Editing Market: By Technology (Zinc Finger Nuclease (ZFN), Clustered regularly interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), Others),  by Application (Cell Line Editing, Targeted gene mutation, Animal Genome Editing, Plant Genome Editing), Product Type (Consumables, Instruments and Software), End-user (Pharmaceutical companies, Biotechnology Companies, Academics, Clinical Research Organizations) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: , Tag:

Report

Description

Gene Editing Market size was valued at USD 4.98 billion in 2021 and is expected to reach USD 16.36 billion by 2028, at a CAGR of 18.5% during the forecast period 2022-2028. Gene editing or genome editing is the type of genetic editing where DNA is inserted, replaced, or deleted in the genome of an organism in order to treat a specific disease by using molecular scissors or engineered nuclease. These nucleases create site-specific double-stranded breaks in desired locations in the genome. The induced double-stranded breaks are repaired through nonhomologous end-joining or homologous recombination resulting in targeted mutations (edits). Biotechnology and pharmaceutical sectors dominate the gene-editing market due to their applications in drug discovery and therapeutics. Rise in the usage of CRISPR and ZFN, companies are investing in innovative research for the development of novel gene-editing techniques. Many players are adopting various strategies which include collaborations for R&D outsourcing, mergers, and acquisitions, strategic or manufacturing activities that are driving the growth of the gene-editing market. For instance, in 2014, Thermo Fisher acquired Life technologies, to create unbeatable leadership in life sciences, research, specialty diagnostics, and applied markets. In 2014, Sigma-Aldrich Corporation (U.S.) entered into an agreement with Broad Institute of MIT and Harvard (U.S.) to use CRISPR technology. High growth potential in emerging regions provides lucrative opportunities to industry players.

Gene Editing Market

MARKET SUMMARY
-
18.5%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 18.5%
  • Largest Market– North-America
  • Fastest Growing Market– Asia-Pacific

Gene Editing Market

  • The global gene editing market report gives a comprehensive outlook on aquaculture across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
  • The report on the global gene editing market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, application, technology, end user, and region.
Key Players
  • Horizon Discovery Group plc,
  • Origene Technologies, Inc.
  • System Biosciences, Inc.
  • Sangamo Therapeutics, Inc.
Gene Editing Market

Drivers And Restraints

Rise in the prevalence rate of cancer & other genetic disorders, increasing preference in the personalized medicine, companies investments towards R&D, and growth of biotechnology and pharmaceutical industries, increase in private and public sector funding, rapid advancements in sequencing and gene editing technologies, applications in various drug discovery processes are some of the factors propelling the growth of the gene-editing market. However, the global gene editing market is hindered by stringent government regulations to approve gene mutation projects, ethical issues, unavailability of gene editing-based therapeutics in the market, and lack of awareness among people regarding the safety of genetic interventions.


North-America got significant share

Gene Editing Market

On the basis of geographical regions, the gene-editing market is categorized into five regions: Europe, North America, Latin America, Asia Pacific, and Middle East & Africa. The gene editing market is dominated by North America due to the strong growth trend in the pharmaceuticals and biotechnology industries. Emerging economies of the Asia Pacific and Latin America are expected to show significant growth in the gene-editing market due to an increase in the number of laboratories in these regions and the development of existing ones for automation of various instrumentation systems, the expansion of leading gene-editing companies, and increased R&D spending.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

developments

  • In July 2017Cellectiswas granted the European Patent for the invention of the genetically engineering T-cells by adopting RNA-guided endonucleases, such as CRISPR associated protein 9 (Cas9) or Centromere and Promoter Factor 1(Cpf1 )
  • In July 2017 Sangamo Therapeutics, Inc. received the U.S.FDA Fast Track designation for in vivo gene editing product candidates SB-318 and SB-913 to treat Mucopolysaccharidosis Type I (MPS I) and MPS II
  • In November 2016, OriGene Technologies entered strategic agreement with EdiGene (Beijing, China) for the development of gene-wide knockout cells from laboratory cell lines which are commonly used

Key

Features of the Report

Gene Editing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Gene Editing Market Introduction
2.1. Global Gene Editing Market – Taxonomy
2.2. Global Gene Editing Market –Definitions
2.2.1. Product Type
2.2.2. Technology
2.2.3. Application
2.2.4. Region
3. Global Gene Editing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Current Trends
3.5. Global Gene Editing Market Dynamic Factors – Impact Analysis
3.6. Mergers, Acquisitions, and Collaborations
4. Global Gene Editing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Gene Editing Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Reagents & Consumables
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Software & Systems
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Services
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Gene Editing Market, By Technology, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. CRISPR
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. TALEN
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. ZFN
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Antisense
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Gene Editing Market, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. Cell Line Engineering
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Genetic Engineering
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Diagnostic Applications
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Drug Discovery & Development
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Gene Editing Market, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. Pharmaceutical and Biotechnology Companies
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Academic and Research Institutes
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Contract Research Organizations
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Gene Editing Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. MEA
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Gene Editing Market – Opportunity Analysis Index, By Product Type, Technology, Application, and End User, and Country, 2022 – 2028
10. North America Gene Editing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Reagents & Consumables
10.1.2. Software & Systems
10.1.3. Services
10.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. CRISPR
10.2.2. TALEN
10.2.3. ZFN
10.2.4. Antisense
10.2.5. Others
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Cell Line Engineering
10.3.2. Genetic Engineering
10.3.3. Diagnostic Applications
10.3.4. Drug Discovery & Development
10.3.5. Others
10.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Academic and Research Institutes
10.4.3. Contract Research Organizations
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.5.1. United States
10.5.2. Canada
10.6. North America Gene Editing Market – Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2016-2027
10.7. North America Gene Editing Market Dynamics – Trends
11. Europe Gene Editing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Reagents & Consumables
11.1.2. Software & Systems
11.1.3. Services
11.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. CRISPR
11.2.2. TALEN
11.2.3. ZFN
11.2.4. Antisense
11.2.5. Others
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Cell Line Engineering
11.3.2. Genetic Engineering
11.3.3. Diagnostic Applications
11.3.4. Drug Discovery & Development
11.3.5. Others
11.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Academic and Research Institutes
11.4.3. Contract Research Organizations
11.5. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.5.1. UK
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Gene Editing Market – Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2016-2027
11.7. Europe Gene Editing Market Dynamics – Trends
12. Asia Pacific Gene Editing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Reagents & Consumables
12.1.2. Software & Systems
12.1.3. Services
12.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. CRISPR
12.2.2. TALEN
12.2.3. ZFN
12.2.4. Antisense
12.2.5. Others
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Cell Line Engineering
12.3.2. Genetic Engineering
12.3.3. Diagnostic Applications
12.3.4. Drug Discovery & Development
12.3.5. Others
12.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Academic and Research Institutes
12.4.3. Contract Research Organizations
12.5. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. ANZ
12.5.4. Japan
12.5.5. Rest of APAC
12.6. Asia Pacific Gene Editing Market – Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2016-2027
12.7. Asia Pacific Gene Editing Market Dynamics – Trends
13. MEA Gene Editing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Reagents & Consumables
13.1.2. Software & Systems
13.1.3. Services
13.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. CRISPR
13.2.2. TALEN
13.2.3. ZFN
13.2.4. Antisense
13.2.5. Others
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Cell Line Engineering
13.3.2. Genetic Engineering
13.3.3. Diagnostic Applications
13.3.4. Drug Discovery & Development
13.3.5. Others
13.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Academic and Research Institutes
13.4.3. Contract Research Organizations
13.5. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of MEA
13.6. MEA Gene Editing Market – Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2016-2027
13.7. MEA Gene Editing Market Dynamics – Trends
14. Latin America Gene Editing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
14.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Reagents & Consumables
14.1.2. Software & Systems
14.1.3. Services
14.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. CRISPR
14.2.2. TALEN
14.2.3. ZFN
14.2.4. Antisense
14.2.5. Others
14.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Cell Line Engineering
14.3.2. Genetic Engineering
14.3.3. Diagnostic Applications
14.3.4. Drug Discovery & Development
14.3.5. Others
14.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Pharmaceutical and Biotechnology Companies
14.4.2. Academic and Research Institutes
14.4.3. Contract Research Organizations
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Argentina
14.5.4. Rest of LA
14.6. Latin America Gene Editing Market – Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2016-2027
14.7. Latin America Gene Editing Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Merck KGaA
15.2.2. Sangamo
15.2.3. Editas Medicine
15.2.4. Precision Biosciences
15.2.5. CRISPR Therapeutics
15.2.6. Intellia Therapeutics, Inc.
15.2.7. Caribou Biosciences, Inc.
15.2.8. Cellectis S.A.
15.2.9. AstraZeneca
15.2.10. Integrated DNA Technologies, Inc.
15.2.11. Egenesis Inc.
15.2.12. GenScript
15.2.13. OriGene Technologies, Inc.
15.2.14. Lonza
15.2.15. Thermo Fisher Scientific, Inc.
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Merck KGaA
  • Sangamo
  • Editas Medicine
  • Precision Biosciences
  • CRISPR Therapeutics
  • Intellia Therapeutics, Inc
  • Caribou Biosciences, Inc.
  • Cellectis S.A.
  • AstraZeneca
  • Integrated DNA Technologies, Inc.
  • Egenesis Inc.
  • GenScript
  • OriGene Technologies, Inc.
  • Lonza
  • Thermo Fisher Scientific, Inc.

Description

Gene Editing Market size was valued at USD 4.98 billion in 2021 and is expected to reach USD 16.36 billion by 2028, at a CAGR of 18.5% during the forecast period 2022-2028. Gene editing or genome editing is the type of genetic editing where DNA is inserted, replaced, or deleted in the genome of an organism in order to treat a specific disease by using molecular scissors or engineered nuclease. These nucleases create site-specific double-stranded breaks in desired locations in the genome. The induced double-stranded breaks are repaired through nonhomologous end-joining or homologous recombination resulting in targeted mutations (edits). Biotechnology and pharmaceutical sectors dominate the gene-editing market due to their applications in drug discovery and therapeutics. Rise in the usage of CRISPR and ZFN, companies are investing in innovative research for the development of novel gene-editing techniques. Many players are adopting various strategies which include collaborations for R&D outsourcing, mergers, and acquisitions, strategic or manufacturing activities that are driving the growth of the gene-editing market. For instance, in 2014, Thermo Fisher acquired Life technologies, to create unbeatable leadership in life sciences, research, specialty diagnostics, and applied markets. In 2014, Sigma-Aldrich Corporation (U.S.) entered into an agreement with Broad Institute of MIT and Harvard (U.S.) to use CRISPR technology. High growth potential in emerging regions provides lucrative opportunities to industry players.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX